Tyler's Departure As FDA Chief Counsel Leaves Another Chair To Fill
This article was originally published in The Tan Sheet
Executive Summary
Ralph Tyler is leaving FDA 18 months after taking the helm as the agency's chief counsel.
You may also be interested in...
People In Brief
Former FDA Chief Counsel Tyler joins Venable; Perrigo appoints de Velarde as regulatory affairs manager; USP shakes up its executive team; Neutra Corp. names Morrissey president and CEO; more people in brief
People In Brief
Former FDA Chief Counsel Tyler joins Venable; Perrigo appoints de Velarde as regulatory affairs manager; USP shakes up its executive team; Neutra Corp. names Morrissey president and CEO; more people in brief
FDA Congressional Relations, Internal Structure May Change With Sharfstein Exit
The departure of Principal Deputy Commissioner Josh Sharfstein provides FDA an opportunity to take stock of its relationship with Congress and to re-evaluate its organizational structure.